Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 72603-198

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 72603-198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure 1 Zole)

A bar graph titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' comparing Zoledronic acid injection 4 mg (n=86) to Pamidronate 90 mg (n=99). The y-axis shows percentage of complete responders, with Zoledronic acid reaching about 85% and Pamidronate about 65%. A significance marker indicates P=0.002 between the two groups.*

FDA Label Image

Structure (Stru Zole)

Chemical structure diagram of Zoledronic acid showing its molecular framework with nitrogen-containing rings and two phosphonic acid groups.*

FDA Label Image

Image Description (Zole Carton North)

Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate solution for intravenous infusion after dilution. The label states it is for a single-dose 5 mL vial, sterile, and not for direct injection. Manufacturer is Northstar Rx LLC, product of India, with storage instructions and dilution warnings included.*

FDA Label Image

Image Description (Zole Formula)

The image shows a formula for calculating creatinine clearance (CrCl), including adjustments for female patients. It displays a mathematical expression involving age, weight, serum creatinine, and a gender-specific factor, relevant to assessing kidney function.*

FDA Label Image

Image Description (Zole Label North)

Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) single-dose vial by Northstar Rx LLC. The injection is for intravenous infusion after dilution, with instructions not for direct injection and dose must be diluted. Includes manufacturer details, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.